Meningioma 1 anticorps
-
- Antigène Voir toutes Meningioma 1 (MN1) Anticorps
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Meningioma 1 est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC)
- Purification
- Immunogen affinity purified
- Pureté
- ≥95 % as determined by SDS-PAGE
- Immunogène
- meningioma(disrupted in balanced translocation) 1
- Isotype
- IgG
- Top Product
- Discover our top product MN1 Anticorps primaire
-
-
- Indications d'application
- IHC: 1:20-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Date de péremption
- 12 months
-
- Antigène
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
- Autre désignation
- MN1 (MN1 Produits)
- Synonymes
- anticorps MGCR, anticorps MGCR1, anticorps MGCR1-PEN, anticorps dJ353E16.2, anticorps MN1 proto-oncogene, transcriptional regulator, anticorps MN1
- Sujet
- Synonyms: Background:Transcriptional activator which specifically regulates expression of TBX22 in the posterior region of the developing palate. Required during later stages of palate development for growth and medial fusion of the palatal shelves. Promotes maturation and normal function of calvarial osteoblasts, including expression of the osteoclastogenic cytokine TNFSF11/RANKL. Necessary for normal development of the membranous bones of the skull(By similarity). May play a role in tumor suppression(Probable).
- ID gène
- 4330
- UniProt
- Q10571
-